Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephen D. Rubin
Stephen D. Rubin
AstraZeneca
Endocrinology
Internal medicine
Medicine
Aromatase inhibitor
Testosterone
5
Papers
520
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels
2005
Clinical Endocrinology
Ryan H. Dougherty
Jacqueline L. Rohrer
Douglas Hayden
Stephen D. Rubin
Benjamin Z. Leder
Show All
Source
Cite
Save
Citations (33)
Anastrazole and oral contraceptives: a novel treatment for endometriosis.
2005
Fertility and Sterility
Lisa L. Amsterdam
William C. Gentry
Smeta Jobanputra
Michael Wolf
Stephen D. Rubin
Serdar E. Bulun
Show All
Source
Cite
Save
Citations (178)
Safety and Efficacy of Anastrozole for the Treatment of Pubertal Gynecomastia: A Randomized, Double-Blind, Placebo-Controlled Trial
2004
The Journal of Clinical Endocrinology and Metabolism
Paul V. Plourde
Edward O. Reiter
Hann-Chang Jou
Paul E. Desrochers
Stephen D. Rubin
Barry B. Bercu
Frank B. Diamond
Philippe F. Backeljauw
Show All
Source
Cite
Save
Citations (90)
Effects of Aromatase Inhibition in Elderly Men with Low or Borderline-Low Serum Testosterone Levels
2004
The Journal of Clinical Endocrinology and Metabolism
Benjamin Z. Leder
Jacqueline L. Rohrer
Stephen D. Rubin
Jose Gallo
Christopher Longcope
Show All
Source
Cite
Save
Citations (119)
Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.
2003
The Journal of Pediatrics
Erica A. Eugster
Stephen D. Rubin
Edward O. Reiter
Paul V. Plourde
Hann-Chang Jou
Ora Hirsch Pescovitz
Show All
Source
Cite
Save
Citations (100)
1